Co-reporter:Dejan Gagoski, Zhenyu Shi, Lars Keld Nielsen, Claudia E. Vickers, Stephen Mahler, Robert Speight, Wayne A. Johnston, Kirill Alexandrov
Journal of Biotechnology 2017 Volume 259(Volume 259) pp:
Publication Date(Web):10 October 2017
DOI:10.1016/j.jbiotec.2017.07.014
•Putative enzymes from gene databases are becoming accessible due to low cost of gene synthesis.•Cell-free protein expression allows the expression of identified putative genes.•Novel glucanase and xylanase assays are compatible with cell-free produced proteins.•A streamlined pipeline integrating the steps described above has been established.•Putative glucanases and xylanases were characterized using this pipeline.The rapid expansion in the number of sequenced genomes and metagenomes provides an exceptional resource for mining of the enzymes with biotechnologically relevant properties. However, the majority of protein production and analysis methods are not sufficiently cost-efficient and scalable to experimentally verify the results of computational genomic mining. Here, we present a pipeline based on Leishmania tarentolae cell-free system that was used to characterize 30 putative thermostable endo-1,4-β-glucanases and xylanases identified in public genomic databases. In order to analyse the recombinant proteins without purification, novel high-throughput assays for glucanase and xylanase activities were developed. The assays rely on solubilisation of labelled particulate substrates performed in multiwell plates. Using this approach both acidophilic and thermophilic enzymes were identified. The developed approach enables rapid discovery of new biotechnologically useful enzymes.
Co-reporter:Zhong Guo, Lindy Murphy, Viktor Stein, Wayne A. Johnston, Siro Alcala-Perez, and Kirill Alexandrov
Journal of the American Chemical Society 2016 Volume 138(Issue 32) pp:10108-10111
Publication Date(Web):July 27, 2016
DOI:10.1021/jacs.6b06342
Biosensors with direct electron output hold promise for nearly seamless integration with portable electronic devices. However, so far, they have been based on naturally occurring enzymes that significantly limit the spectrum of detectable analytes. Here, we present a novel biosensor architecture based on analyte-driven intermolecular recombination and activity reconstitution of a re-engineered component of glucometers: PQQ-glucose dehydrogenase. We demonstrate that this sensor architecture can be rapidly adopted for the detection of immunosuppressant drugs, α-amylase protein, or protease activity of thrombin and Factor Xa. The biosensors could be stored in dried form without appreciable loss of activity. We further show that ligand-induced activity of the developed biosensors could be directly monitored by chronoamperometry, enabling construction of disposable sensory electrodes. We expect that this architecture could be expanded to the detection of other biochemical activities, post-translational modifications, nucleic acids, and inorganic molecules.
Co-reporter:Zhong Guo, Wayne A. Johnston, Viktor Stein, Palraj Kalimuthu, Siro Perez-Alcala, Paul V. Bernhardt and Kirill Alexandrov
Chemical Communications 2016 vol. 52(Issue 3) pp:485-488
Publication Date(Web):27 Oct 2015
DOI:10.1039/C5CC07824E
Electrochemical biosensors convert biological events to an electrical current. To date most electrochemical biosensors exploit activities of naturally occurring enzymes. Here we demonstrated that insertion of a calmodulin domain into the redox enzyme PQQ-glucose dehydrogenase resulted in a selective Ca2+ biosensor that could be used to rapidly measure Ca2+ concentrations in human biological fluids. We were able to convert a point-of-care glucometer into Ca2+ monitor by refurbishing it with the developed biosensor. We propose that similar engineering strategies may be used to create highly specific electrochemical biosensors to other analytes. Compatibility with cheap and ubiquitous amperometric detectors is expected to accelerate progression of these biosensors into clinical applications.
Co-reporter:Zhenling Cui; Viktor Stein; Zakir Tnimov; Sergey Mureev
Journal of the American Chemical Society 2015 Volume 137(Issue 13) pp:4404-4413
Publication Date(Web):March 30, 2015
DOI:10.1021/ja5131963
Genetic code expansion is a key objective of synthetic biology and protein engineering. Most efforts in this direction are focused on reassigning termination or decoding quadruplet codons. While the redundancy of genetic code provides a large number of potentially reassignable codons, their utility is diminished by the inevitable interaction with cognate aminoacyl-tRNAs. To address this problem, we sought to establish an in vitro protein synthesis system with a simplified synthetic tRNA complement, thereby orthogonalizing some of the sense codons. This quantitative in vitro peptide synthesis assay allowed us to analyze the ability of synthetic tRNAs to decode all of 61 sense codons. We observed that, with the exception of isoacceptors for Asn, Glu, and Ile, the majority of 48 synthetic Escherichia coli tRNAs could support protein translation in the cell-free system. We purified to homogeneity functional Asn, Glu, and Ile tRNAs from the native E. coli tRNA mixture, and by combining them with synthetic tRNAs, we formulated a semisynthetic tRNA complement for all 20 amino acids. We further demonstrated that this tRNA complement could restore the protein translation activity of tRNA-depleted E. coli lysate to a level comparable to that of total native tRNA. To confirm that the developed system could efficiently synthesize long polypeptides, we expressed three different sequences coding for superfolder GFP. This novel semisynthetic translation system is a powerful tool for tRNA engineering and potentially enables the reassignment of at least 9 sense codons coding for Ser, Arg, Leu, Pro, Thr, and Gly.
Co-reporter:Viktor Stein
PNAS 2014 Volume 111 (Issue 45 ) pp:15934-15939
Publication Date(Web):2014-11-11
DOI:10.1073/pnas.1405220111
The bottom-up design of protein-based signaling networks is a key goal of synthetic biology; yet, it remains elusive due to
our inability to tailor-make signal transducers and receptors that can be readily compiled into defined signaling networks.
Here, we report a generic approach for the construction of protein-based molecular switches based on artficially autoinhibited
proteases. Using structure-guided design and directed protein evolution, we created signal transducers based on artificially
autoinhibited proteases that can be activated following site-specific proteolysis and also demonstrate the modular design
of an allosterically regulated protease receptor following recombination with an affinity clamp peptide receptor. Notably,
the receptor’s mode of action can be varied from >5-fold switch-OFF to >30-fold switch-ON solely by changing the length of
the connecting linkers, demonstrating a high functional plasticity not previously observed in naturally occurring receptor
systems. We also create an integrated signaling circuit based on two orthogonal autoinhibited protease units that can propagate
and amplify molecular queues generated by the protease receptor. Finally, we present a generic two-component receptor architecture
based on proximity-based activation of two autoinhibited proteases. Overall, the approach allows the design of protease-based
signaling networks that, in principle, can be connected to any biological process.
Co-reporter:Monika Köhnke, Steven Schmitt, Nicholas Ariotti, Andrew M. Piggott, Robert G. Parton, Ernest Lacey, Robert J. Capon, Kirill Alexandrov, Daniel Abankwa
Chemistry & Biology 2012 Volume 19(Issue 7) pp:866-874
Publication Date(Web):27 July 2012
DOI:10.1016/j.chembiol.2012.05.019
Protein prenylation is required for membrane anchorage of small GTPases. Correct membrane targeting is essential for their biological activity. Signal output of the prenylated proto-oncogene Ras in addition critically depends on its organization into nanoscale proteolipid assemblies of the plasma membrane, so called nanoclusters. While protein prenylation is an established drug target, only a handful of nanoclustering inhibitors are known, partially due to the lack of appropriate assays to screen for such compounds. Here, we describe three cell-based high-throughput screening amenable Förster resonance energy transfer NANOclustering and Prenylation Sensors (NANOPS) that are specific for Ras, Rho, and Rab proteins. Rab-NANOPS provides the first evidence for nanoclustering of Rab proteins. Using NANOPS in a cell-based chemical screen, we now identify macrotetrolides, known ionophoric antibiotics, as submicromolar disruptors of Ras nanoclustering and MAPK signaling.Graphical AbstractFigure optionsDownload full-size imageDownload high-quality image (170 K)Download as PowerPoint slideHighlights► Cellular FRET biosensors for Ras, Rho, and Rab membrane anchorage were developed ► We provide evidence for Rab protein nanoclustering on cellular membranes ► Two FRET biosensors were demonstrated to be suitable for high-throughput screening ► Macrotetrolides were identified as nanoclustering and MAPK signaling disruptors
Co-reporter:Dr. Debapratim Das;Zakir Tnimov;Dr. Uyen T. T. Nguyen;Dr. Govindaraju Thimmaiah;Dr. Harriet Lo;Dr. Daniel Abankwa;Dr. Yaowen Wu; Dr. Roger S. Goody; Dr. Herbert Waldmann; Dr. Kirill Alexrov
ChemBioChem 2012 Volume 13( Issue 5) pp:674-683
Publication Date(Web):
DOI:10.1002/cbic.201100733
Abstract
Protein modification with isoprenoid lipids affects hundreds of signaling proteins in eukaryotic cells. Modification of isoprenoids with reporter groups is the main approach for the creation of probes for the analysis of protein prenylation in vitro and in vivo. Here, we describe a new strategy for the synthesis of functionalized phosphoisoprenoids that uses an aminederivatized isoprenoid scaffold as a starting point for the synthesis of functionalized phosphoisoprenoid libraries. This overcomes a long-standing problem in the field, where multistep synthesis had to be carried out for each individual isoprenoid analogue. The described approach enabled us to synthesize a range of new compounds, including two novel fluorescent isoprenoids that previously could not be generated by conventional means. The fluorescent probes that were developed using the described approach possess significant spectroscopic advantages to all previously generated fluorescent isoprenoid analogue. Using these analogues for flow cytometry and cell imaging, we analyzed the uptake of isoprenoids by mammalian cells and zebrafish embryos. Furthermore, we demonstrate that derivatization of the scaffold can be coupled in a one-pot reaction to enzymatic incorporation of the resulting isoprenoid group into proteins. This enables rapid evaluation of functional groups for compatibility with individual prenyltransferases and identification of the prenyltransferase specific substrates.
Co-reporter:Dr. Yao-Wen Wu; Dr. Roger S. Goody; Dr. Kirill Alexrov
ChemBioChem 2011 Volume 12( Issue 18) pp:2813-2821
Publication Date(Web):
DOI:10.1002/cbic.201100377
Abstract
Rab GTPases play a key role in the regulation of membrane trafficking. Post-translational geranylgeranylation is critical for their biological activity and is conferred by Rab geranylgeranyl transferease (RabGGTase), together with an accessory factor, Rab escort protein (REP). Mechanistic studies of Rab prenylation and identification of RabGGTase inhibitors require sensitive reporters of Rab prenylation. In the present work, a combination of protein engineering and expressed protein ligation was used to construct a library of semisynthetic Rab7 fluorescent conjugates. In order to avoid synthesis of a large number of fluorescently labeled peptides, we developed a strategy that combined thiol-reactive dye-labeling of cysteine with in vitro protein ligation. Application of this strategy required optimization of labeling and ligation conditions to promote thiol labeling and disfavor intramolecular cyclization. Using this approach, we constructed 46 fluorescent sensors with different spectral properties that reported on the interaction of Rab7 with RabGGTase, REP-1, and the overall prenylation reaction. Two constructs, Rab7Δ3CCK(NBD) and Rab7Δ2SCCC–dans, displayed 2.5- and 1.5-fold increase in fluorescence, respectively, upon prenylation. Moreover, dansyl-, NBD (4-nitro-benzofurazan)-, I-BA-, and I-SO-labeled Rab7 conjugates exhibited two- to tenfold change in fluorescence upon binding to REP or RabGGTase. These fluorescent sensors allowed us to monitor Rab prenylation in real time and to investigate the assembly of Rab–REP binary and Rab–REP–RabGGTase ternary complexes.
Co-reporter:Uyen T. T. Nguyen Dr.;Roger S. Goody Dr.;Kirill Alexrov Dr.
ChemBioChem 2010 Volume 11( Issue 9) pp:1194-1201
Publication Date(Web):
DOI:10.1002/cbic.200900727
Co-reporter:Viktor Stein, Kirill Alexandrov
Trends in Biotechnology (February 2015) Volume 33(Issue 2) pp:101-110
Publication Date(Web):1 February 2015
DOI:10.1016/j.tibtech.2014.11.010
•Engineered protein switches are increasingly used in molecular diagnostics.•Engineered protein switches can be used to sense and actuate cellular functions.•Empirical design rules to construct tailor-engineered protein switches are emerging.•Future synthetic signaling circuits will see networks of engineered protein switches.Protein switches are ubiquitous in biological signal transduction systems, enabling cells to sense and respond to a variety of molecular queues in a rapid, specific, and integrated fashion. Analogously, tailor-engineered protein switches with custom input and output functions have become invaluable research tools for reporting on distinct physiological states and actuating molecular functions in real time and in situ. Here, we analyze recent progress in constructing protein-based switches while assessing their potential in the assembly of defined signaling motifs. We anticipate such systems will ultimately pave the way towards a new generation of molecular diagnostics and facilitate the construction of artificial signaling systems that operate in parallel to the signaling machinery of a host cell for applications in synthetic biology.
Co-reporter:Susanna Kushnir, Ion Cristian Cirstea, Lyudmyla Basiliya, Nataliya Lupilova, Reinhard Breitling, Kirill Alexandrov
Molecular and Biochemical Parasitology (April 2011) Volume 176(Issue 2) pp:69-79
Publication Date(Web):1 April 2011
DOI:10.1016/j.molbiopara.2010.12.002
The trypanosomatid protozoon Leishmania tarentolae is a well-established model organism for studying causative agents of several tropical diseases that was more recently developed as a host for recombinant protein production. Although several expression architectures based on foreign RNA polymerases have been established for this organism, all of them rely on integration of the expression cassette into the genome. Here, we exploit a new type of expression architecture based on linear elements. These expression vectors were propagated in Escherichia coli as circular plasmids and converted into linear episomes with telomere-like structures prior to transfection of L. tarentolae. Overexpression of recombinant proteins in transgenic organisms exceeding 10% of total cellular protein, one of the highest overexpression levels obtained in a eukaryotic organism for a cytosolic protein. We show that the linear elements are stably propagated in L. tarentolae cells over long periods of time (>90 generations) without major changes in structure or expression yields. Overexpressing cultures can be obtained without clonal selection of the transfected cells. To establish the utility of the developed system for protein production in a parallelized format, we expressed 37 cytosolic, peripheral, and membrane proteins as fusions with EGFP in L. tarentolae using linear vectors. We detected the expression of 30 of these targets and describe the preparative purification of two arbitrarily selected proteins.Graphical abstractDownload high-res image (65KB)Download full-size imageResearch highlights▶ The protozoon Leishmania tarentolae was developed as a host for recombinant protein production. ▶ We present a new type of expression architecture for L. tarentolae based on linear elements. ▶ Overexpression of recombinant proteins in transgenic organisms reaches up to 30% of total cellular protein using this architecture.
Co-reporter:Dejan Gagoski, Sergey Mureev, Nichole Giles, Wayne Johnston, Mareike Dahmer-Heath, Dubravka Škalamera, Thomas J. Gonda, Kirill Alexandrov
Journal of Biotechnology (10 February 2015) Volume 195() pp:1-7
Publication Date(Web):10 February 2015
DOI:10.1016/j.jbiotec.2014.12.006
•A suite of universal Gateway-based in vitro expression vectors was constructed.•The performance of vectors was tested in E. coli and Leishmania cell-free systems.•Rolling Circle DNA Amplification was used to prepare templates for in vitro translation.Although numerous techniques for protein expression and production are available the pace of genome sequencing outstrips our ability to analyze the encoded proteins. To address this bottleneck, we have established a system for parallelized cloning, DNA production and cell-free expression of large numbers of proteins. This system is based on a suite of pCellFree Gateway destination vectors that utilize a Species Independent Translation Initiation Sequence (SITS) that mediates recombinant protein expression in any in vitro translation system. These vectors introduce C or N terminal EGFP and mCherry fluorescent and affinity tags, enabling direct analysis and purification of the expressed proteins. To maximize throughput and minimize the cost of protein production we combined Gateway cloning with Rolling Circle DNA Amplification. We demonstrate that as little as 0.1 ng of plasmid DNA is sufficient for template amplification and production of recombinant human protein in Leishmania tarentolae and Escherichia coli cell-free expression systems. Our experiments indicate that this approach can be applied to large gene libraries as it can be reliably performed in multi-well plates. The resulting protein expression pipeline provides a valuable new tool for applications of the post genomic era.
Co-reporter:Zhong Guo, Wayne A. Johnston, Viktor Stein, Palraj Kalimuthu, Siro Perez-Alcala, Paul V. Bernhardt and Kirill Alexandrov
Chemical Communications 2016 - vol. 52(Issue 3) pp:NaN488-488
Publication Date(Web):2015/10/27
DOI:10.1039/C5CC07824E
Electrochemical biosensors convert biological events to an electrical current. To date most electrochemical biosensors exploit activities of naturally occurring enzymes. Here we demonstrated that insertion of a calmodulin domain into the redox enzyme PQQ-glucose dehydrogenase resulted in a selective Ca2+ biosensor that could be used to rapidly measure Ca2+ concentrations in human biological fluids. We were able to convert a point-of-care glucometer into Ca2+ monitor by refurbishing it with the developed biosensor. We propose that similar engineering strategies may be used to create highly specific electrochemical biosensors to other analytes. Compatibility with cheap and ubiquitous amperometric detectors is expected to accelerate progression of these biosensors into clinical applications.